Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

202 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Specific scoring systems to predict survival of patients with high-risk myelodysplastic syndrome (MDS) and de novo acute myeloid leukemia (AML) after intensive antileukemic treatment based on results of the EORTC-GIMEMA AML-10 and intergroup CRIANT studies.
Oosterveld M, Suciu S, Muus P, Germing U, Delforge M, Belhabri A, Aul C, Selleslag D, Ferrant A, Marie JP, Amadori S, Jehn U, Mandelli F, Hess U, Hellström-Lindberg E, Cakmak-Wollgast S, Vignetti M, Labar B, Willemze R, de Witte T. Oosterveld M, et al. Among authors: vignetti m. Ann Hematol. 2015 Jan;94(1):23-34. doi: 10.1007/s00277-014-2177-y. Epub 2014 Aug 7. Ann Hematol. 2015. PMID: 25096636
Myelodysplastic syndromes in childhood: description of seven cases.
Vitale A, Testi AM, Moleti ML, Vignetti M, Arcese W, Fenu S, Cedrone M, De Felice L, Amadori S, Mandelli F. Vitale A, et al. Among authors: vignetti m. Ann Hematol. 1994 May;68(5):241-5. doi: 10.1007/BF01737424. Ann Hematol. 1994. PMID: 8018765
Interleukin 2 treatment in acute myelogenous leukemia.
Mandelli F, Vignetti M, Tosti S, Andrizzi C, Foa R, Meloni G. Mandelli F, et al. Among authors: vignetti m. Stem Cells. 1993 Jul;11(4):263-8. doi: 10.1002/stem.5530110402. Stem Cells. 1993. PMID: 8401249 Review.
Interleukin-2 therapy in relapsed acute myelogenous leukemia.
Meloni G, Vignetti M, Pogliani E, Invernizzi R, Allione B, Mirto S, Sica S, Leoni F, Selleri C, Mandelli F. Meloni G, et al. Among authors: vignetti m. Cancer J Sci Am. 1997 Dec;3 Suppl 1:S43-7. Cancer J Sci Am. 1997. PMID: 9457393 Clinical Trial.
Clinicobiological features and outcome of acute promyelocytic leukemia occurring as a second tumor: the GIMEMA experience.
Pulsoni A, Pagano L, Lo Coco F, Avvisati G, Mele L, Di Bona E, Invernizzi R, Leoni F, Marmont F, Mele A, Melillo L, Nosari AM, Pogliani EM, Vignetti M, Visani G, Zagonel V, Leone G, Mandelli F. Pulsoni A, et al. Among authors: vignetti m. Blood. 2002 Sep 15;100(6):1972-6. doi: 10.1182/blood-2001-12-0312. Blood. 2002. PMID: 12200354 Free article. Clinical Trial.
202 results